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Summary Objective: To produce practical evidence-based guidelines for themanage-
ment of paediatric epilepsy in secondary care settings. Design: Question-speciﬁc sys-
tematic literature review and local service audit. Main outcome measures: Grade of
recommendation for speciﬁc management issues. Results: There is little good quality
research to support many existing epilepsy guidelines for secondary care. Conclusion:
Practical guidelines for the provision of children’s epilepsy services can be evidence
inﬂuenced but until more relevant research is undertaken, not evidence based.
© 2003 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
Introduction
Many groups have suggested standards, guidelines
and recommendations for management of patients
with epilepsy. These often fail to address the par-
ticular problems of paediatrics1, address mainly
tertiary care2 and often do not consider the prac-
tical issues of implementation in the NHS. A recent
Government publication from the Clinical Stan-
dards Advisory Group3 has provided a comprehen-
sive review and provided recommendations ‘‘that
would improve the standards of care provided by
the NHS for people with epilepsy’’.
There is a paucity of published data about clin-
ical activity and provision of secondary care ser-
vices for children with epilepsy. As care of children
and their families is strikingly different to adult
services, there is a clear need for a sensible, ef-
ﬁcient and evidence-based provision for this pop-
ulation. This paper provides data from a prospec-
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tive study of epilepsy in a District General Hospital
(DGH). The aim of this study was to review our cur-
rent practice in all patients attending a DGH, re-
view the literature and hopefully inform the debate
on service provision and clinical practice especially
in respect of the recent recommendation on stan-
dards of service provision3. Speciﬁc questions are
addressed and discussed with reference to the best
available evidence.
Methods
York District Hospital is a medium to large sized Dis-
trict Hospital that serves a population catchment
area of approximately 300 000. There are 2900
births per year and 52 000 children below the age
of 17. There are four general paediatric and one
community consultant who each have an additional
specialist interest, one of whom has an interest in
epilepsy and another in childhood disability.
A prospective study of all patients attending the
hospital over a period of 1 year from April 2000 to
April 2001 was performed. All ﬁve consultants and
1059-1311/$ – see front matter © 2003 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
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secretaries agreed to participate. All patients with
epilepsy, both those with new and existing diag-
noses, aged between 3months and 16 years were in-
cluded. Epilepsy was deﬁned by the diagnosis being
made by the consultant. Patients with febrile con-
vulsions and those with a single seizure of less than
30minutes duration were not included. Cases were
ascertained prospectively from clinic attendances,
from ward admissions using hospital diagnostic cod-
ing records and from prospective manual checking
of ward admission books. Patients who had no hos-
pital attendances or admissions during the period
were not included in the review. Data on each case
were collected and analysed by R.A.S.
To address the need for auditable standards of
care, a series of literature searches was performed
on the Cochrane Library and Medline database (us-
ing PubMed and OVID interfaces). These searches
addressed questions regarding the management of
paediatric epilepsy within the secondary care set-
ting, and were produced by consensus between the
two authors.
In general, a hierarchical approach was used,
based on the Oxford Centre for Evidence-based
Medicine Levels of Evidence (www.cebm.net/
levels), and where possible a grade of recommen-
dation is appended according to this document.
Results
Epidemiology [How common is it?]
How many cases should we see?
Over 1 year there were 60 newly diagnosed and
151 existing cases of epilepsy seen in the depart-
ment. Epidemiological data would indicate that
if all cases were seen we should expect to see
22—79 (43—152 cases per 100 000 children) new
cases of epilepsy per year and have a prevalence
of approximately 155—311 (3—6 cases per 1000
population)4,5. There are methodological difﬁcul-
ties in studying epilepsy epidemiology6 and ﬁgures
extrapolated from epidemiological studies may not
always reﬂect the clinical caseload in a given area
especially if only cases of active or treated epilepsy
are included7.
We feel that we have complete ascertainment of
cases attending our clinics. We are the only DGH
in our area but it is possible that some cases are
managed solely in primary care, in other centres
or in the adult epilepsy clinic. We are aware of
eight cases of epilepsy either seen in another centre
or not reviewed during the year of the study (and
therefore not included). Most cases seen in the re-
gional centre are on a shared care basis with consul-
Suggested Standards:
DGH epilepsy caseload should be between 55
and 100 new cases/100 000 population per
year, with total caseload of approximately
5/1000 population [Grade B]
All children with epilepsy should be under
secondary care [Grade D]
tants in our department. A postal survey in the UK
reported that 28% of children with epilepsy had not
been to a hospital clinic within the last 12 months3.
Epilepsy diagnosis [How is it diagnosed?]
Do all patients get an epilepsy diagnosis?
How many patients have epilepsy as only one of
their clinical problems?
Are all patients correctly diagnosed?
In our study, 173 cases (82%) of children re-
ceived an epilepsy diagnosis according to the 1989
ILEA Classiﬁcation8. Of the 79 cases with partial
epilepsy, 22 were idiopathic and 57 symptomatic.
Of the 70 with generalised epilepsy, 65 were idio-
pathic and 5 symptomatic, including 4 with Lennox
Gastaut Syndrome. Nineteen other cases had been
given speciﬁc epilepsy syndrome diagnoses. There
were ﬁve cases that had initially presented with
infantile spasms, three of whom were idiopathic.
There were a further 38 (18%) who had not had
their epilepsy classiﬁed, of whom 14 were idio-
pathic. In a prospective study using the same syn-
drome classiﬁcation, a diagnosis was assigned by
paediatric neurologists for 99% of 614 children with
epilepsy, 57% had localisation-related epilepsy and
28% generalised. In 12—14% of cases, it could not
be determined whether the seizures were of a fo-
cal or generalised origin9. Much has changed since
these guidelines on classiﬁcation were agreed and
there is a current review and revision ongoing with
a draft available at www.epilepsy.org. The cur-
rently proposed diagnostic scheme will make use of
standardised terminology and concepts to describe
individual patients.
Table 1 gives the associated medical diagnoses in
symptomatic cases and serves to illustrate the di-
versity of associated problems many of which also
require considerable expertise to manage, adding
to the complexity of care required for these pa-
tients. This has particular implications for the prac-
tical clinic management of these children (see be-
low).
We cannot say, as it was not a speciﬁc aim of this
study, for how many of these children the epilepsy
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Table 1 Diagnoses in 88 patients with symptomatic
epilepsy.
Cerebral palsy 30
Quadriplegia 15
Hemiplegia 9
Athetoid 4
Diplegia 1
Not classiﬁed 1
SLD no speciﬁc diagnosis 8
Previous encephalitis (2 Herpes, I HUS) 5
Focal cortical dysplasia 4
Chromosome abnormality (9p
deletion, inversion
chromosome 1, partial trisomy
chromosome 8, XYY)
4
Previous meningitis 4
Mesial temporal sclerosis 3
Autism plus SLD 3
3 microcephaly plus SLD 3
CVA 2
2 MLD, no speciﬁc diagnosis 2
Angelman’s Syndrome 2
Rett’s Syndrome 2
Hydrocephalus with shunt
ATRX Syndrome
Neuroﬁbromatosis
Septo-optic dysplasia
Pfeiffer’s Syndrome
Periventricular leukomalacia
Aicardi’s Syndrome
Astrocytoma
Ganglioneuroma
MRI small? Glioma
ADEM
MRI cystic structure
Hemimegalencephaly
Leukodystrophy
Down’s Syndrome
Tuberose sclerosis
SLD: severe learning difﬁculty (IQ < 50); MLD (mod-
erate; IQ = 50—75).
is incorrectly diagnosed. While the diagnosis of
seizures and epilepsy can be straight forward, it
can also be one of the greatest clinical challenges,
especially in children10,11. The rate of misdiagnosis
is a strong argument for specialist neurology care
but until adequate resources are available to allow
a specialised service for all cases this will not be
possible. A way around this could be some form
of case note review with specialists for those not
referred for a second opinion. A full review of all
cases diagnosed is again impractical, but a ‘quality
control’ review may well be beneﬁcial. There are
no relevant data to suggest what proportion would
be appropriate or feasible.
Suggested Standards:
85% of DGH epilepsy patients should have an
ILEA epilepsy diagnosis made within 1 year
of diagnosis [Grade D]
Perform a case note review on a sample of
cases not referred to a paediatric neurolo-
gist [Grade D]
Neurophysiology
How is it investigated?
York is relatively well served as a DGH in having
a consultant neurophysiologist without a long wait-
ing list (Kitson and Shorvon3 reported that only 39%
of relevant Hospital Trusts had EEG facilities but
that 95% of hospital-based patients had undergone
an EEG). In our sample, 91% of newly diagnosed pa-
tients had received an EEG at some point. Overall,
94% of cases had had an EEG of which 73% were ab-
normal. There were more abnormalities in the EEGs
of those with pre-existing epilepsy (82% with one
or more recording abnormal) compared with 47% in
the new diagnosis group. Nine cases had undergone
ambulatory EEG and six video-EEG. Some children
did not receive an EEG: of the patients with ex-
isting epilepsy, one parent declined the offer, two
had severe cerebral palsy, two autism and in one
child with severe learning difﬁculties the EEG was
attempted but failed (the only case of a failure to
record an EEG).
There is no clear guideline indicating who should
undergo an EEG and when. Decisions need to be
made on an individual basis as presentations of
epilepsy in childhood are quite variable. It is im-
portant that the purpose and role of an EEG in
the diagnosis of epilepsy is understood. The or-
ganisation and provision of paediatric neurophys-
iology should be considered as an integral com-
ponent in the development of a managed clinical
network12.
Suggested Standards:
95% of new DGH epilepsy patients should have
an EEG within 2 months [Grade D]
They should be reported by a consultant
neurophysiologist or neurologist with
an interest or training in paediatric en-
cephalography interpretation [Grade D]
Further EEGs may be required in up to 50%
of patients [Grade D]
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Neuroimaging [How is it investigated]?
Which patients should undergo neuroimaging?
Are there any guidelines?
In York, dedicated general anaesthetic (GA) mag-
netic resonance imaging (MRI) lists are available
once every month, with the capacity to scan 48 pa-
tients each year. We no longer perform MRI under
deep sedation. For those children who do not re-
quire GA, further slots are available. In acute cases,
CT imaging is available urgently at all times (and
may be followed up with an elective MRI scan). The
scans are reported by a consultant radiologist with
an interest in paediatrics who works in close li-
aison with paediatric neuroradiology colleagues at
the local tertiary centre. Ex-premature infants who
have received cranial ultrasound scans that demon-
strated abnormalities may not have received other
forms of imaging.
In total 49% of our childhood epilepsy population
had some form of neuroimaging; 18% of cases re-
ceived a CT scan (66% were abnormal); 33% an MRI
scan (54% were abnormal) and 6% both. In three
cases there was an initial normal CT scanwith an ab-
normality detected on subsequent MRI scan. There
were 4% who were imaged by cranial ultrasound in
the neonatal period of which all were abnormal.
Overall, when considering all modalities of neu-
roimaging, abnormalities were revealed in 64% of
cases. There were six patients with symptomatic
partial epilepsy in the existing group who had not
had any form of neuroimaging, three were older
children with cerebral palsy, one had a chromosome
abnormality and one had ATRX Syndrome. One pa-
tient declined the offer of MRI.
The preferred mode of imaging is MRI as it is
clear that it will occasionally detect lesions in oth-
erwise normal patients with normal CT scans13.
Furthermore, a routine MRI may miss lesions de-
tectable on higher resolution MRI using speciﬁc
epilepsy protocols.
The decision to perform neuroimaging generally
is based on accurate seizure classiﬁcation and syn-
drome diagnosis. MRI is the ideal form of imaging
and recommended in suspected symptomatic par-
tial epilepsies, speciﬁc syndromes, such as West’s
Syndrome, and in infants less than 12 months, but
not recommended in children with primary gener-
alised or benign epilepsies3,14—19. The emphasis in
decision making now is not considering which pa-
tients need a scan, but deciding on those who do
not need a scan. Patients who are being considered
for epilepsy surgery clearly require more detailed
imaging, possibly including functional MRI and iso-
tope studies that need to be performed in special-
ist centres. It is clear from this that the proportion
of children who are scanned (with MRI, or possibly
CT) will reﬂect the caseload in terms of speciﬁc di-
agnoses.
Suggested Standards:
All patients without a clear diagnosis of pri-
mary generalised or benign partial epilepsy
syndrome should have an MRI head within
1 year of diagnosis [Grade D]
They should be reported by a consultant radi-
ologist with an interest in paediatric radi-
ology who also has access to second opinion
where necessary [Grade D]
Referrals for second opinion [How is
management organised?]
Howmany patients are referred for second opinion?
Which patients should be referred to a paediatric
neurologist for a second opinion?
In the Yorkshire region at the time of this audit
there were 2.5 whole time equivalent paediatric
neurologists for a population of 5 million. One pae-
diatric neurologist visits York 6 times per year. Over
the year, there are 12—18 new patient slots for all
outpatient neurology referrals with 18—30 for fol-
low up. In addition to the shared clinics, advice is
available by phone and urgent cases can be referred
direct to the regional referral centre. Of the 151 pa-
tients with existing epilepsy, 22% had been seen by
a paediatric neurologist at some time and 7% were
under active review. If one includes the patients
with newly diagnosed epilepsy, 15% overall had seen
a neurologist and 5% were under active review.
Brown et al.1 stated that 20—40% of patients
with epilepsy would require input from a special-
ist epilepsy service although their recommenda-
tions were not speciﬁcally for children. There are
currently no evidence-based guidelines on which
patients should be referred to a paediatric neu-
rologist. The referral rate to specialist paediatric
neurologists is, however, inevitably inﬂuenced and
limited by resources. In the recent National Audit
of Epilepsy-related Deaths, 8 of 22 children were
considered to have inadequate access to appropri-
ate care20. Surgery is increasingly being considered
for epilepsy patients. In our study, eight (4%) pa-
tients with epilepsy had seen paediatric neurosur-
geons in four different regional centres. It has been
conservatively estimated that between 5 and 10%
of patients with drug-resistant focal epilepsy could
be offered surgery3. In the context of 30—35% of
children requiring add-on anti-epileptic drug (AED)
therapy and up to 10—25% of children with epilepsy
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being misdiagnosed11, there is considerable scope
for involving paediatric neurologists in the care of
these children although it is not possible to de-
ﬁne a standard for recommended referral rates to
tertiary services.
We believe that if there was a managed network
with lead clinicians and adequate support from re-
gional or supra-regional centres with the full range
of tertiary epilepsy support services, it would lead
to better co-ordinated care for children with severe
and complex epilepsy.
Suggested Standard:
All patients who request a second opinion
should have access to one [Grade D]
Clinic organisation [How is management
organised?]
How should services in a DGH be conﬁgured?
Who should manage cases?
What type of clinic?
All ﬁve paediatric consultants saw children with
epilepsy, the majority seeing the consultant with
an interest in the disorder. Some of the consultants
saw relatively small numbers of patients. Access
to psychology is available by referral to the lo-
cal Child and Adolescent Mental Health Team with
whom there is a weekly liaison meeting21. There
were a total of 544 outpatient appointments dur-
ing the year for patients with epilepsy of which
30% of appointments are in the epilepsy clinic,
with 55% in general paediatric clinics and 25% in
child development clinics (CDC). The majority of
children with epilepsy in this study are clearly not
being seen in speciﬁc clinics, as advised by some
recommendations22. The mean number of review
appointments per case was 2.6 appointments per
year, new patients also averaged 2.6 appoint-
ments but most were studied for less than a year.
We could ﬁnd no data recommending how often
children with epilepsy should be reviewed, nor
on the relative beneﬁts of consultant-led versus
consultant-delivered management.
The key problem faced currently is of time and
resources. If one was to plan a service based on
the actual caseload of our department, offering
30minutes appointments for new and 15minutes
for return appointments (RCPCH recommenda-
tions) allowing a 10% non-attendance rate (our
departmental average), study leave and annual
leave requirements, it would require one and a
half clinic sessions every week. If one was to group
all new referrals into a ‘seizure’ clinic it could in-
clude 250 new referrals and 2000 follow ups in a
year22 which would require 200 clinics per year or
3 to 4 clinics per week. We could ﬁnd no evidence
to support a recommendation regarding the need
for all paroxysmal disorders to be seen in a seizure
clinic.
A Cochrane Review23 of epilepsy clinics versus
general neurology or medical clinics found no tri-
als of suitable quality to review. Morrow24,25 in a
comparison of adult general versus adult specialist
epilepsy clinic found that patients attending the
specialist clinic were more likely to be followed
up, to be seen more often and to receive a greater
continuity of care than those attending a general
neurology clinic. We could ﬁnd no similar study
involving children, but a recent audit by Mar et
al.26 reported an increase in knowledge of epilepsy
in parents and children attending a specialist
epilepsy as opposed to general clinic. Williams et
al.27 also reported on the beneﬁts of establish-
ing a multidisciplinary clinic for children. Kitson
and Shorvon3 reported that at general clinics only
17% of clinicians had access to epilepsy specialist
nurses compared to 58% of clinicians at specialist
clinics.
As epilepsy management is increasingly complex,
it makes sense that there should be a lead clini-
cian in each DGH managing the majority if not all
cases of epilepsy and that this person should inter-
act closely with neurological colleagues in a tertiary
centre possibly as part of a ‘managed network’12. It
would also be feasible for smaller DGHs to work to-
gether to jointly provide a combined epilepsy clinic
for a larger locality as part of such a network. There
may be training issues for existing departments who
do not have a consultant with an interest or training
in epilepsy and for newly qualiﬁed general paedia-
tricians who do not receive neurology training.
Suggested Standard:
The majority of cases should be managed by a
lead clinician in amultidisciplinary epilepsy
clinic in a DGH (CSAG) [Grade D]
Epilepsy nurses [What treatments are used?]
Are children’s epilepsy nurses useful?
Which kind of patients should have access to an
epilepsy nurse?
Should all departments that manage children
with epilepsy have an epilepsy nurse?
Only 42% of patients had seen the paediatric
epilepsy nurse, with a higher proportion of those
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seeing the consultant with an interest in epilepsy
being referred to the nurse (similar ﬁnding as Webb
et al.14). At the time of this study the epilepsy
nurse was only funded part time for 1 session per
week by a pharmaceutical company. She has the
Diploma of Epilepsy Care from the Metropolitan
University of Leeds.
There is a paucity of research evidence to sup-
port the introduction of epilepsy nursing services.
A Cochrane Review of specialist epilepsy nurses28
concluded that there was no evidence that spe-
cialist epilepsy nurses improve outcomes for adults
with epilepsy, but the conﬁdence intervals are
wide and do not exclude signiﬁcant beneﬁt (level
1a-). There are a number of audits of patient and
parental views that indicate dissatisfaction with the
amount and quality of information provided14,27,29
or that they would prefer to speak to someone
other than a doctor about the condition3,30. There
are also a number of publications available re-
porting on the beneﬁts of establishing such a ser-
vice mainly in relation to adult services3,31—34 but
also for children35. This highlights a difﬁculty in
producing evidence-based recommendations for
health services organisation: funding and research
resources are not available to rigorously investi-
gate potential changes in services. What research
is undertaken is often ‘spare time’, unfunded, and
descriptive. Kitson and Shorvon3 reported that 58%
of 77 paediatric neurologists and paediatricians
who ran epilepsy clinics had epilepsy nurses in their
clinics and that only 70% were funded by the NHS.
The key roles for the epilepsy nurse that emerge
from these studies are not that of taking over the
role of the doctor but of enhancing the overall care
by providing continuity, information giving, liaison,
support, administration and education. A DGH may
not need to employ a full time epilepsy nurse, de-
pendent upon the population served, but for useful
continuity it would need to be at least 0.5 WTE.
It is our view that a key person in epilepsy man-
agement could be the epilepsy nurse. We feel that
all patients should be seen by the epilepsy nurse
with the speciﬁc aim of increasing patients and par-
ent knowledge and understanding of epilepsy and
co-ordinating care. This will be especially useful if
patients are being seen by several consultants, in a
number of different clinics.
Suggested Standard:
All patients and their families should have
the opportunity to see a specialist epilepsy
nurse [Grade C]
Antiepileptic drug usage [What treatments
are used?]
Which drugs are being used?
Should there be an agreed protocol?
Which drugs should be used for which patients?
In this study, we have looked at the AEDs pre-
scribed to the patients at their ﬁrst outpatient ap-
pointment in the year. Whilst following each pa-
tient through their prescription year would have
yielded a richer dataset to examine, the physical
constraints on the study team (q.v.) restricted us to
examining this deﬁned event.
Of the new patients, 32% had no treatment
started during the period of study. In the 58% where
treatment was started, nearly nine-tenths (88%)
were commenced on standard ﬁrst line treatment
(sodium valproate or carbamazepine). In the re-
maining ﬁve patients there were speciﬁc reasons
for not using these two drugs. In three teenage
girls lamotrigine was prescribed. A further patient
was prescribed vigabatrin for infantile spasms, and
one was given ethosuximide for absence epilepsy.
Only 7% of existing patients were on no treatment.
The number of AEDs for each existing patient at
the ﬁrst appointment during the period of the study
may be regarded as a quality marker, as over treat-
ment should be avoided. 22% were on two drugs and
reassuringly only 3% were on three drugs and none
on four or more. The number of drugs tried in in-
dividual patients is a reﬂection of the difﬁculty in
achieving control in some cases. In 20% of cases pa-
tients had been tried on four or more AEDs and 7%
on seven or more. In some cases where no medica-
tion has been effective and most options have been
tried, it may be considered a reasonable option to
withhold drug treatments.
One of our patients with severemyoclonic infancy
had a vagal nerve stimulator. None of our patients
has used a ketogenic diet although two were on a
waiting list at the regional centre.
Carpay et al. audited the use of anticonvul-
sants prospectively in a cohort of 494 children with
epilepsy. Treatment was initially withheld in 29%
of the children and after 2 years, 17% still had not
received any anticonvulsant drugs. There were no
serious complications from withholding treatment.
Of the children treated with AEDs, 60% were still
using the ﬁrst anticonvulsant after 2 years, 80%
received monotherapy and 20% polytherapy.
A recent audit of epilepsy-related deaths, how-
ever, indicated that 4 of 22 children who died were
on no treatment and in 10 of the 22 cases there was
deemed to be inadequate drug management. Webb
et al.14 audited use of drugs in the management of
epilepsy using three standards. These are consen-
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sus guidelines that could be adopted in a DGH to
audit epilepsy.
It should be possible to produce some nationally
agreed guidelines on which anticonvulsants should
be used in paediatric practice for the different
types of epilepsy. One example is the drug ad-
vice information available on the National Epilepsy
Association Web site by Richard Appleton (www.e-
epilepsy.org.uk). Although these would have to be
regularly updated they could lead to an improve-
ment in epilepsy AED management. Although there
is not a strong evidence base, this should not be a
reason for not attempting to agree a consensus and
could stimulate future research. A similar process
has occurred for Asthma Management.
At the moment in our department an audit of
prescribing would have to be done manually (as
in this study). If an up to date epilepsy database
of all patients or an electronic prescribing system
was used, this would facilitate audit of drug use in
epilepsy.
Suggested Standards:
Only 20% of children should be on two or more
AEDs.
No patient should be on more than two AEDs
without shared care with a paediatric neu-
rologist.
Patients not responding to two AEDs used ap-
propriately should be referred to a paedi-
atric neurologist [Grade D]
Hospital admissions [How is outcome
measured?]
During the year of the study, there were 41 hos-
pital ward admissions in 25 patients who had a
pre-existing diagnosis of epilepsy (1 patient had
5 admissions). Six of these patients had nine ad-
missions in status epilepticus (one with three
episodes). Of the 60 new cases, 28 patients had
been admitted on 45 occasions. (This included
one patient with nine admissions and another with
four.) Eight ‘new’ patients had nine episodes of
status epilepticus.
This demonstrates that an acute hospital admis-
sion is still a common presentation of new cases of
epilepsy (47% of cases) and therefore still within
the area of general paediatrics. 16% of cases with
pre-existing epilepsy also re-presented to the ward
with recurrences of epilepsy severe enough–—be
that medical or socially severe–—to be admitted.
Smith et al.36 reviewed children presenting to a
DGH accident and emergency department, 26% of
the cases they reviewed were for children with
pre-existing epilepsy. It would be tempting to use
hospital admission rate as a standard for epilepsy
service provision but there is not enough evidence
to be able to use this as a recommendation.
Frequency of seizures [How is outcome
measured?]
Is seizure frequency being recorded?
Is there an agreed method of assessing epilepsy
severity?
The seizure count was taken on the ﬁrst clinic
visit of the period of study. It was possible to record
this from 95% of case notes indicating a high stan-
dard of note keeping. Seizure severity scales have
been described37 but are not widely used. Cur-
rently, there is no universally used classiﬁcation of
seizure frequency or severity for children. Tables 2
and 3 indicate the recorded seizure frequency for
the patients with known epilepsy and those with
a new diagnosis. Those with daily seizures were
having absence seizures.
Although one potential marker of epilepsy sever-
ity, assessing control is far more complex than
simply counting seizure frequency. A key aspect of
management with each patient and their family is
to come to mutually agreed goals for treatment. In
ideal circumstances, this would be complete con-
trol of seizures using one AED with no side effects,
a normal quality of life and a patient and family
Table 2 Frequency of seizures for 151 existing pa-
tients (frequency recorded at ﬁrst appointment of the
year).
Category Number of patients (%)
Seizure free for at least
12 months
50 (33%)
Seizures less than monthly 36 (24%)
Seizures occurring at
least monthly
58 (38%)
Not recorded 7 (5%)
Table 3 Seizure frequency in newly diagnosed pa-
tients at the time of diagnosis.
Category Number of patients
Status epilepticus 2
2 seizures 9
3 seizures 12
4 seizures 5
Several seizures? No 20
Weekly seizures 5
Daily seizures 7
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who fully understand their condition as well as to
reduce epilepsy morbidity and mortality. Parents
and clinicians may not always agree on epilepsy
management decisions as they may have differ-
ing perceptions and beliefs38. Compromises from
achieving complete seizure freedom may be ac-
ceptable in some cases. Because of the variability
of case mix between clinics, it would be difﬁcult to
set a target proportion of cases achieving seizure
freedom for a deﬁned period as a standard al-
though current available data would indicate that
at any one time one third of cases would be seizure
free1.
Suggested Standards:
Each case should have explicit, agreed treat-
ment goals [Grade D]
Recording seizure frequency, severity and ef-
fect on the child’s life will assist in manag-
ing expectations [Grade D]
Audit [How is outcome assessed?]
Are there audit standards?
Do they indicate good quality care?
If met, would they lead to an improvement in
outcome?
There have been a number of published audits
of paediatric epilepsy management. Appleton et
al.39 audited the management of new referrals and
commented that, despite being a national project
supported by the British Paediatric Neurology As-
sociation, response was low with only 50 patients
included. Stewart et al.40 audited the views of 48
parents on standards of care, the majority of which
expressed dissatisfaction with outpatient care and
attitude of staff in schools. Kwong et al.41 showed
that parents of children with epilepsy disclosed
major misunderstandings of the disease and its
medical and psychosocial treatment. Robinson et
al.30 audited a newly established epilepsy clinic
in a tertiary referral centre using a structured
questionnaire administered to parents and where
appropriate children. A high degree of satisfaction
was obtained, however, speciﬁc questions about
additional resources implied a large number of un-
met needs. Williams et al.27 using a questionnaire
determined that the best quality predictor using
parental rating of a multidisciplinary epilepsy clinic
for children was the amount of information given
concerning the diagnosis and treatment of epilepsy.
Webb et al.14 have audited epilepsy care in a sam-
ple of patients against a series of guidelines agreed
by physicians in the hospital and indicated that the
audit process can demonstrate an increase in the
numbers of cases reaching certain agreed manage-
ment criteria. They stated in their discussion that
two potentially useful standards not audited were
those in whom a specialised neurology opinion
should be sought and those who were misdiagnosed
as having epilepsy. Both are more difﬁcult to au-
dit from clinical notes and both more contentious,
although they are clinically very important.
This is the ﬁrst prospective study that provides
actual clinical data on all children attending a DGH
with epilepsy and these data will be of interest to
those planning services for children. We aimed to
produce some standards for epilepsy services in sec-
ondary care. Although, the standards we propose
are largely based on poor quality evidence and are
arbitrary, they are based on recommendations from
previously published reports and what we believe
are realistic and achievable using data from an av-
erage sized UK DGH. We would like to propose that
our standards could be considered when planning
a practical, achievable and evidence-supported
framework for providing high-quality care for chil-
dren with epilepsy. Until further research is pub-
lished, there will be no evidence base available on
which to base such standards of care.
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